NCT00482352
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
COMPLETED
NCT00482352
OBSERVATIONAL
Classification Of Acute Lymphoblastic Leukemia
This clinical trial is studying risk-group classification of patients with newly diagnosed acute lymphoblastic leukemia. Developing a risk-group classification guide may help doctors assign patients with newly diagnosed acute lymphoblastic leukemia to treatment clinical trials.
Inclusion Criteria:
* Newly diagnosed acute lymphoblastic leukemia, defined by any of the following:
* At least 25% blasts in the bone marrow
* Absolute blast count at least 10,000/mm\^3, if bone marrow aspiration is not performed
* No prior registration on this study
Untreated Adult Acute Lymphoblastic Leukemia
Untreated Childhood Acute Lymphoblastic Leukemia
-
- Type: OTHER
- Name: laboratory biomarker analysis
- Description: Correlative studies
- Arm Group Labels: Ancillary-Correlative (marker identification, molecular test)
- Children's Oncology Group